Q1-FY27 · Shiva
The business is not linear... We would urge you to track us on an annual basis.
MOLBIODIAGNOSTICS / language trends
Read confidence between the lines.
Molbio Diagnostics · tone and specificity signals across the available quarters.
Research layer active
Language signals
What changed in management language.
tracked
Q1-FY27 · Shiva
Optra Scan this year will be muted. We don't expect the company to turn profitable in FY27 but going forward 28 and 29 onwards we should see meaningful contribution coming in.
Q1-FY27 · Shiva
Currently about 77% of revenue contributed from test kits. The recurring revenue business has kicked in as per our plans.
Q1-FY27 · Shiva
We are just about getting started in the international landscape so while obviously other diseases will kick in, TB itself has a lot more for us to do.